Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 541 to 98 of 98 entries
Sorted by: Best Match Show Resources per page
On the probability of lymph node negativity in pN0-staged prostate cancer-a theoretically derived rule of thumb for adjuvant needs.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Paulsen F, Bedke J, Wegener D, Marzec J, Martus P, Nann D, Stenzl A, Zips D, Müller AC.
PMID: 34476527
Strahlenther Onkol. 2021 Sep 02; doi: 10.1007/s00066-021-01841-x. Epub 2021 Sep 02.

PURPOSE: The extent of lymphadenectomy and clinical features influence the risk of occult nodes in node-negative prostate cancer. We derived a simple estimation model for the negative predictive value (npv) of histopathologically node-negative prostate cancer patients (pN0) to guide...

Cite
Paulsen F, Bedke J, Wegener D, et al. On the probability of lymph node negativity in pN0-staged prostate cancer-a theoretically derived rule of thumb for adjuvant needs. Strahlenther Onkol. 2021;doi: 10.1007/s00066-021-01841-x.
Paulsen, F., Bedke, J., Wegener, D., Marzec, J., Martus, P., Nann, D., Stenzl, A., Zips, D., & Müller, A. C. (2021). On the probability of lymph node negativity in pN0-staged prostate cancer-a theoretically derived rule of thumb for adjuvant needs. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], . https://doi.org/10.1007/s00066-021-01841-x
Paulsen, Frank, et al. "On the probability of lymph node negativity in pN0-staged prostate cancer-a theoretically derived rule of thumb for adjuvant needs." Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] vol. (2021). doi: https://doi.org/10.1007/s00066-021-01841-x
Paulsen F, Bedke J, Wegener D, Marzec J, Martus P, Nann D, Stenzl A, Zips D, Müller AC. On the probability of lymph node negativity in pN0-staged prostate cancer-a theoretically derived rule of thumb for adjuvant needs. Strahlenther Onkol. 2021 Sep 02; doi: 10.1007/s00066-021-01841-x. Epub 2021 Sep 02. PMID: 34476527.
Copy Download .nbib Format: NLM
Primary immunosuppressive TNI-based conditioning regimens in pediatric patients treated with haploidentical hematopoietic cell transplantation.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]

Wegener D, Lang P, Paulsen F, Weidner N, Zips D, Ebinger M, Holzer U, Döring M, Heinzelmann F.
PMID: 34476532
Strahlenther Onkol. 2022 Jan;198(1):66-72. doi: 10.1007/s00066-021-01840-y. Epub 2021 Sep 02.

PURPOSE: This retrospective analysis aims to address the toxicity and efficacy of a modified total nodal irradiation (TNI)-based conditioning regimen before haploidentical hematopoietic cell transplantation (HCT) in pediatric patients.MATERIALS AND METHODS: Patient data including long-term follow-up were evaluated of...

Cite
Wegener D, Lang P, Paulsen F, et al. Primary immunosuppressive TNI-based conditioning regimens in pediatric patients treated with haploidentical hematopoietic cell transplantation. Strahlenther Onkol. 2021;198(1):66-72doi: 10.1007/s00066-021-01840-y.
Wegener, D., Lang, P., Paulsen, F., Weidner, N., Zips, D., Ebinger, M., Holzer, U., Döring, M., & Heinzelmann, F. (2022). Primary immunosuppressive TNI-based conditioning regimens in pediatric patients treated with haploidentical hematopoietic cell transplantation. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 198(1), 66-72. https://doi.org/10.1007/s00066-021-01840-y
Wegener, D, et al. "Primary immunosuppressive TNI-based conditioning regimens in pediatric patients treated with haploidentical hematopoietic cell transplantation." Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] vol. 198,1 (2022): 66-72. doi: https://doi.org/10.1007/s00066-021-01840-y
Wegener D, Lang P, Paulsen F, Weidner N, Zips D, Ebinger M, Holzer U, Döring M, Heinzelmann F. Primary immunosuppressive TNI-based conditioning regimens in pediatric patients treated with haploidentical hematopoietic cell transplantation. Strahlenther Onkol. 2022 Jan;198(1):66-72. doi: 10.1007/s00066-021-01840-y. Epub 2021 Sep 02. PMID: 34476532.
Copy Download .nbib Format: NLM
Showing 541 to 98 of 98 entries